regulatory decision making d. kathleen wright, reviewer division of microbiology office of in vitro...
TRANSCRIPT
![Page 1: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/1.jpg)
Regulatory Decision Regulatory Decision MakingMaking
D. Kathleen Wright, Reviewer D. Kathleen Wright, Reviewer Division of Microbiology Division of Microbiology
Office of In Vitro Diagnostic Device Office of In Vitro Diagnostic Device Evaluation & Safety (Evaluation & Safety (OIVDOIVD))
Food and Drug AdministrationFood and Drug Administration
Clinical Virology Symposium Clinical Virology Symposium
April 27, 2003April 27, 2003
![Page 2: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/2.jpg)
Risk Based Risk Based
ClassificationClassification
![Page 3: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/3.jpg)
Class IClass I
Most Most exemptexempt from pre-mkt. from pre-mkt. notification [510(k)]notification [510(k)]
ReservedReserved: : EBV, TBEBV, TB Limitation to exemptionLimitation to exemption::
IgM AssaysIgM Assays Life threatening diseasesLife threatening diseases
![Page 4: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/4.jpg)
Class IIClass II
Reasonable assurance of Reasonable assurance of safety and effectiveness safety and effectiveness
can can be obtained by be obtained by applying applying "special controls" "special controls"
![Page 5: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/5.jpg)
Regulatory OptionsRegulatory OptionsClass I & IIClass I & II
TraditionalTraditional 510(k) 510(k) AbbreviatedAbbreviated 510(k) w/std. 510(k) w/std. SpecialSpecial 510(k)-Data 510(k)-Data
Summary Summary 3rd3rd Party review Party review De novoDe novo::
Automatic ClassificationAutomatic Classification
![Page 6: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/6.jpg)
Class IIIClass III Present a potential, Present a potential,
unreasonable risk of illness unreasonable risk of illness or or injury.injury.
No PredicateNo Predicate PMAPMA (Pre-market approval) (Pre-market approval) ModularModular PMA PMA
![Page 7: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/7.jpg)
CLIA CategoriesCLIA Categories
0
200
400
600
800
1000
1200
1400
1600
1800
2000
FY1999 FY2000 FY2001 FY2002
WaivedModerateHigh
![Page 8: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/8.jpg)
Waiver CriteriaWaiver Criteria Accuracy and precisionAccuracy and precision
Utilized with an FDA cleared Utilized with an FDA cleared assayassay
Field studies @ 3 sites w/20 Field studies @ 3 sites w/20 participants/siteparticipants/site
Statistical evaluation @ FDAStatistical evaluation @ FDA
SimplicitySimplicity Specimen unprocessed Specimen unprocessed No intervention during studyNo intervention during study Fail safe mechanism Fail safe mechanism Step by step instructionsStep by step instructions
![Page 9: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/9.jpg)
CHANGESCHANGES Re-think regulatory processRe-think regulatory process
ProtectProtect public health in a less public health in a less burdensome mannerburdensome manner
PostPost-market surveillance-market surveillance
GMP enforcementGMP enforcement
Streamline premarket reviewsStreamline premarket reviews
More interaction-More interaction-stakeholders stakeholders
![Page 10: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/10.jpg)
RESULTRESULT New OfficeNew Office - IVDs - IVDs
One stop shoppingOne stop shopping
CombineCombine – – IVD review w/IVD review w/
Compliance & SurveillanceCompliance & Surveillance
![Page 11: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/11.jpg)
Overriding ThemesOverriding Themes
Total Product Life Cycle (Total Product Life Cycle (TPLCTPLC))
Shift Shift directiondirection - premarket to postmarket - premarket to postmarket
GlobalGlobal market regulatory harmonization market regulatory harmonization
LeastLeast burdensome burdensome
![Page 12: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/12.jpg)
Functional ComponentsFunctional Components PremarketPremarket
Streamline/standardize Streamline/standardize review review
Pre-IDE ProtocolPre-IDE Protocol Shift labeling toward Shift labeling toward educational/informational educational/informational
PostmarketPostmarket Active surveillance & outreachActive surveillance & outreach IVD IVD webpage webpage
httphttp://www.fda.gov/cdrh/oivd://www.fda.gov/cdrh/oivd
![Page 13: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/13.jpg)
Continued Office Continued Office ActivitiesActivities
BioterrorismBioterrorism Emerging InfectionsEmerging Infections Professional Round-TableProfessional Round-Table IVD Round-TableIVD Round-Table
![Page 14: Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food](https://reader036.vdocuments.mx/reader036/viewer/2022082821/5697bfdb1a28abf838cb0ab7/html5/thumbnails/14.jpg)
SummarySummarySummarySummaryPre-marketPre-market
Premarket Review –Premarket Review – Design, Performance & LabelingDesign, Performance & Labeling
Guidance documents, StandardsGuidance documents, Standards Investigational device exemptions (Investigational device exemptions (Pre-Pre-
IDEIDE)) GMP’sGMP’s & Quality Systems & Quality Systems
Post-marketPost-market Medical Device Reporting (Medical Device Reporting (MDRMDR)) Safety AlertsSafety Alerts: Advisories, technical : Advisories, technical
reports, recallsreports, recalls